Table 1.
Drug resistance mechanisms of Acinetobacter baumannii1
Drug class | Mechanism of resistance | Example of effector molecules | Reference(s) |
---|---|---|---|
Aminoglycosides | Modifying enzymes | ||
Acetyltransferase | ACC | Bakour et al. (2013) | |
16S rRNA methylation | ArmA | Doi et al. (2007) | |
Phosphotransferase | APHA1, StrA, StrB | McGann et al. (2014), Nigro et al. (2013) | |
Adenylytransferase | AadAB | Bakour et al. (2013) | |
Efflux pump | AdeABC, AdeM | Magnet et al. (2001), Su et al. (2005) | |
Carbapenems | Carbapenemases | Oxa-23, -58, -64, -65, -66, -68, -70, -71, -78, -79, -80 | Perez et al. (2007) |
Loss of protein function | CarO | Mussi et al. (2005) | |
Decreased expression | 33–36 kDa OMP | Clark (1996) | |
Efflux pump | AdeIJK | Coyne et al. (2011) | |
Cephalosporins | Efflux pump | AdeIJK | Coyne et al. (2011) |
β-lactamases | AmpC | Rezaee et al. (2013) | |
Lincosamides | Efflux pump | AdeFGH, AdeIJK, MsrA, MsrB | Coyne et al. (2011), Taitt et al. (2014) |
Macrolides | Efflux pump | AdeABC, MsrA, MsrB | Magnet et al. (2001), Taitt et al. (2014) |
Monobactams | Efflux pump | AdeIJK | Coyne et al. (2011) |
Penicillins | Altered penicillin-binding proteins | PBP1-3,5-8 | Cayo et al. (2011) |
β-lactamases | PER-1, TEM-1, VEB-1, CTX-M | Bae et al. (2011), Perez et al. (2007), Walther-Rasmussen & Hoiby (2004) | |
Metallo-β-lactamases | IMP-1, -2, -4, -5, -6, -11 VIM-2, NDM-1 | Walsh et al. (2005) | |
Efflux pump | AdeABC, AdeIJK | Yum et al. (2002), Jones et al. (2014) | |
Decreased expression | 46 kDa OMP | Magnet et al. (2001), Coyne et al. (2011) | |
Polypeptides | Gene mutations | pmrAB | Lesho et al. (2013) |
phosphoethanolamine modification of lipid A | PmrC | Arroyo et al. (2011) | |
Quinolones/Fluoroquinolone | Efflux pump | AdeABC, AdeIJK, AdeM, AdeFGH | Magnet et al. (2001), Su et al. (2005), Coyne et al. (2011) |
Production of protective proteins | QnrA | Touati et al. (2008) | |
Gene mutations | gyrA, parC | Hamouda & Amyes, | |
Rifamycin | Efflux pump | AdeIJK | Coyne et al. (2011) |
ADP-ribosyltransferase | ARR-2 | Houang et al. (2003) | |
Sulfonamides | Drug-resistant variant | Sul1, Sul2 | Nigro et al. (2013) |
Tetracyclines | Efflux pump | AdeABC, AdeIJK | Magnet et al. (2001), |
TetAB | Coyne et al. (2011) | ||
Decreased expression | CarO, OmpA38, OmpA32, OmpW | Guardabassi et al. (2000) | |
Other | Aminocoumarin | ||
Efflux pump | AdeIJK | Coyne et al. (2011) | |
Chloramphenicol | |||
Efflux pump | AdeABC, AdeFGH, AdeIJK, CmlA, CraA | Magnet et al. (2001), Coyne et al. (2011) | |
Acetyltransferase | Cat | Turton et al. (2005) | |
Fusidic acid | |||
Efflux acid | AdeIJK | Coyne et al. (2011) | |
Streptogramin | |||
Efflux pump | MsrA, MsrB | Taitt et al. (2014) | |
Tigecycline | |||
Efflux pump | AdeABC, AdeIJK | Coyne et al. (2011) | |
Trimethoprim | |||
Efflux pump | AdeABC, AdeFGH, AdeIJK, AdeM | Coyne et al. (2011) | |
Drug-resistant variant | FolA, DrfA1, DrfA7, DrfA19 | Taitt et al. (2014) |
Drug-resistance mechanisms vary greatly among strains and combinations of drug resistance genes are different. Many of these genes have been acquired by A. baumannii to confer drug-resistance, while some occur naturally.